Back to Trades
Sell4
Travere Therapeutics, Inc.
TVTX
Total Value
$3.7M
Net $1.8M sold
Sales
$1.8M
2 transactions
Company Information
- Company Name
- Travere Therapeutics, Inc.
- Ticker Symbol
- TVTX
- CIK
- 0001438533
Insider Information
- Name
- Dube Eric M
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Jan 27, 2026
- Transaction Date
- Jan 23, 2026
- Accession Number
- 0001763494-26-000001
- Form Type
- 4
- Net Trading Amount
- -$1.8M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 23, 2026 | Common Stock | 8,135 | $15.46 | Exercise | $125.8K |
| Jan 23, 2026 | Common Stock | 8,135 | $30.01 | Sale | $244.2K |
| Jan 27, 2026 | Common Stock | 51,865 | $15.46 | Exercise | $801.8K |
| Jan 27, 2026 | Common Stock | 51,865 | $30.10 | Sale | $1.6M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 23, 2026 | Derivative | 8,135 | $15.46 | Exercise | $125.8K |
| Jan 27, 2026 | Derivative | 51,865 | $15.46 | Exercise | $801.8K |
Footnotes
- (F1)This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
- (F2)The weighted average sale price for the transaction reported was $30.0127, and the range of prices were between $30.00 and $30.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- (F3)The weighted average sale price for the transaction reported was $30.097, and the range of prices were between $30.00 and $30.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- (F4)The stock option is fully vested and exercisable.